Close Menu
    Facebook X (Twitter) YouTube LinkedIn
    Trending
    • Europe’s accessibility standard moved in September. Your deadline is December.
    • OCT and H3C Join Forces to Expand Advanced ICT Solution Distribution
    • Leaders should stay grounded in ethics, keep customers at the center, and build a culture where people can grow and succeed together
    • How to Make Your Website Accessible and Better for Everyone
    • Shaping Pakistan’s Future: CXO Global Forum Joins Visionaries at Leaders in Islamabad Business Summit
    • CITADEL Pakistan and Muhammad Abbas & Co. Sign MOU to Support Pakistan’s Startup Ecosystem
    • Why Most AI Strategies Fail Before They Even Start
    • The Code Is Starting to Write Itself. So What’s a Software Company For? Intelligence is moving into the plumbing of how organizations operate, and most people are watching the wrong layer
    News – CxO NewsNews – CxO News
    • Home
    • Press Release
    • Business
    • Tech
    • Video
    Facebook X (Twitter) YouTube LinkedIn
    Saturday, October 3
    News – CxO NewsNews – CxO News
    Home » Cancer Vaccines Nearing Completion in Russia, Announces President Putin
    Business

    Cancer Vaccines Nearing Completion in Russia, Announces President Putin

    cxonnewsnewsBy cxonnewsnewsFebruary 17, 2024No Comments2 Mins Read
    cancer
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Russian President Vladimir Putin recently expressed optimism about the progress made by Russian scientists in developing a cancer vaccine during a televised statement delivered as part of a seminar on future technologies in Moscow.

    Putin highlighted that Russian scientists are on the brink of creating “cancer vaccines and immunomodulatory drugs of a new generation” and expressed hope that these vaccines would soon be effectively utilized for individual therapy. However, he refrained from providing specific details regarding the type of cancer these vaccines would target or their mechanisms of action.

    Meanwhile, in the United Kingdom, the government has signed a contract with BioNTech, a German-based company, to kickstart personalized cancer treatments. The collaboration aims to assist 10,000 patients by the year 2030.

    Furthermore, there have been promising advancements in an experimental cancer vaccine developed by Moderna and Merck & Co. This vaccine has demonstrated potential in reducing the risk of death from melanoma, an aggressive form of skin cancer, by half after three years of therapy.

    The World Health Organization (WHO) emphasizes the importance of existing vaccines for hepatitis B and human papillomaviruses (HPV) in preventing specific type of cancers. Hepatitis B vaccines help reduce the risk of liver cancer, while HPV vaccines can prevent cervical cancer and other related malignancies.

    Amidst the COVID-19 pandemic, Russia developed its own vaccine, known as Sputnik V, which was exported to numerous countries. However, domestically, the vaccine encountered resistance and skepticism. To instill confidence in the vaccine’s safety and efficacy, President Putin personally received the Sputnik vaccine.

    These developments underscore ongoing efforts and progress in research and vaccine development, offering hope for improved cancer treatment options and prevention strategies in the future.

    Visit CxO Global FORUM or CxO News Live for all the latest updates.

     

    Don’t forget to follow us on social media for the latest updates on digital transformation, startup news, Pakistani tech updates, industry insights, and thought leadership:

    Linked In: https://www.linkedin.com/company/cxo-globalforum/mycompany/

    Youtube: https://www.youtube.com/@CxOGlobalTV

    Instagram: https://www.instagram.com/cxoglobal.forum/
    BioNtech cancer prevention Cancer Vaccines medical innovation Merck & Co Moderna Sputnik V vaccine development Vladimir Putin WHO
    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    cxonnewsnews

    Related Posts

    Europe’s accessibility standard moved in September. Your deadline is December.

    October 1, 2026

    CITADEL Pakistan and Muhammad Abbas & Co. Sign MOU to Support Pakistan’s Startup Ecosystem

    September 17, 2026

    Payoneer vs Wise Pakistan: Which Is the Better Freelancer Payout Platform?

    September 2, 2026
    picks
    Stay In Touch
    • Facebook
    • Twitter
    • YouTube
    Don't Miss
    Expert Insights

    Europe’s accessibility standard moved in September. Your deadline is December.

    October 1, 202606 Mins Read

    What changed, what has not, and why the gap between them is the cheapest window…

    OCT and H3C Join Forces to Expand Advanced ICT Solution Distribution

    September 23, 2026

    Leaders should stay grounded in ethics, keep customers at the center, and build a culture where people can grow and succeed together

    September 21, 2026

    How to Make Your Website Accessible and Better for Everyone

    September 19, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    News around thought leaders & corporate industry. World is moving towards knowledge economy and the change of paradigm shift is here.

    • Contact us: hello@news.cxoforum.global
    Facebook X (Twitter) YouTube LinkedIn

    All rights reserved © By CxO Global Forum

    EVEN MORE NEWS

    Europe’s accessibility standard moved in September. Your deadline is December.

    OCT and H3C Join Forces to Expand Advanced ICT Solution Distribution

    Leaders should stay grounded in ethics, keep customers at the center, and build a culture where people can grow and succeed together

    How to Make Your Website Accessible and Better for Everyone

    Shaping Pakistan’s Future: CXO Global Forum Joins Visionaries at Leaders in Islamabad Business Summit

    CITADEL Pakistan and Muhammad Abbas & Co. Sign MOU to Support Pakistan’s Startup Ecosystem

    POPULAR CATEGORY

    • Press Release
    • Technology
    • Business
    • Startups
    • Heathcare
    • Education
    • Mobiles

    LINKS

    • Disclaimer
    • Privacy
    • Advertisement
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.